update on compounded semaglutide $99/mo (vs $1,349 Wegovy) Hims & Hers stock falls
Description
Pregnancy, Nursing, and Fertility Considerations Semaglutide is pregnancy category C, meaning animal studies have shown adverse effects but human data remain limited
fields Lilly, Novo (via the UBT-251 license and an internal NNC program), D&D Pharmatech (DD-03 / DD-15, both linked to Metsera and therefore now Pfizer after the 2025 acquisition), Protagonist, Cascade, and Rani
It contains no stimulants, no hormones, and has shown excellent tolerability in human trials
The standard pharmacokinetic rule is that 97% of a drug clears after five half-lives
Yet many women are prescribed these drugs with little discussion of how they intersect with reproductive or midlife care
